Concepedia

Thomas P. Parks

TP

Statistics

Publications

10

Citations

1.3K

H-Index

10

Active since

1980

Affiliations

Boehringer Ingelheim (United States)(Current)

Yale University

University of California, Los Angeles

Thomas P. Parks is an author at Boehringer Ingelheim (United States) specializing in life sciences, signal transduction, and inflammatory signaling.

Publications per year

1980–2024

10

Publications

10

Transcriptional Regulation of the Intercellular Adhesion Molecule-1 Gene by Inflammatory Cytokines in Human Endothelial Cells

Harry C. Ledebur, Thomas P. Parks · Journal of Biological Chemistry · 1995 · 542 citations · Full text

, , +17

Intercellular adhesion molecule-1 gene expression in human endothelial cells. Differential regulation by tumor necrosis factor-alpha and phorbol myristate acetate.

Stanley J. Wertheimer, Christina L. Myers, Robert W. Wallace et al. · Journal of Biological Chemistry · 1992 · 259 citations · Full text

, , +17

Upregulation of Bcl-x and Bfl-1 as a potential mechanism of chemoresistance, which can be overcome by NF-κB inhibition

Qingwen Cheng, Ho H. Lee, Ying Li et al. · Oncogene · 2000 · 105 citations

, , +10

Specificities of CD40 signaling: Involvement of TRAF2 in CD40-induced NF-κB activation and intercellular adhesion molecule-1 up-regulation

Ho H. Lee, Paul W. Dempsey, Thomas P. Parks et al. · Proceedings of the National Academy of Sciences · 1999 · 87 citations · Full text

, , +17

Cabozantinib and nivolumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Hedyeh Ebrahimi, Nazlı Dizman, Luís Meza et al. · Nature Medicine · 2024 · 82 citations · Full text

, , +17

1–5 of 10